Use of non-parenteral prescription only medications by non-registered ambulance staff

D_wilson made this Freedom of Information request to North West Ambulance Service NHS Trust

Automatic anti-spam measures are in place for this older request. Please let us know if a further response is expected or if you are having trouble responding.

The request was successful.

Dear North West Ambulance Service NHS Trust,

Please could you supply any information you have regarding the trust's policy on non-registered staff (eg. ambulance technicians) using non-parenteral Prescription only medications such as salbutamol?

Does the trust have a legal framework or policy that describes the legal mechanism for this under the Human medicines regulations 2012?

Has there ever been any feedback given or action taken by the MHRA or CQC in relation to use of salbutamol or ipratropium bromide by ambulance technicians?

If the trust has a medicines policy or medicines governance policy, please could you share this?

Yours faithfully,

D_wilson

FOI Enquiries, North West Ambulance Service NHS Trust

Thank you for your request for information which is currently being
reviewed under the terms of the Freedom of Information Act 2000. We will
contact you again with a response to your request within the 20 working
days commitment outlined in the Freedom of Information Act. If there are
any queries with your request which we need to clarify with you, we will
contact you at the earliest opportunity.

Please note: NWAS is currently working very hard to deal with challenges
posed by the coronavirus (COVID-19) pandemic. We will do our best to
respond to any FOI requests within the usual 20 working day deadline, but
please bear with us during this busy time. Thank you for your
understanding.

 

 

[1]NWAS Logo
This message (and any associated files) is intended only for the use of
the individual or entity to which it is addressed and may contain
information that is confidential, subject to copyright or constitutes a
trade secret. If you are not the intended recipient you are hereby
notified that any dissemination, copying or distribution of this message,
or files associated with this message, is strictly prohibited. If you have
received this message in error, please notify us immediately by replying
to the message and deleting it from your computer. Messages sent to and
from us may be monitored.
Internet communications cannot be guaranteed to be secure or error-free as
information could be intercepted, corrupted, lost, destroyed, arrive late
or incomplete, or contain viruses. Therefore, we do not accept
responsibility for any errors or omissions that are present in this
message, or any attachment, that have arisen as a result of e-mail
transmission. If verification is required, please request a hard-copy
version. Any views or opinions presented are solely those of the author
and do not necessarily represent those of the company.
Please note that North West Ambulance Service may monitor email traffic
data and also the content of email for the purposes of security and staff
training.
Please consider the environment before printing this email.

--------------------------------------------------------------------------

References

Visible links

Alice Finch, North West Ambulance Service NHS Trust

Dear D Wilson

 

Please see below information in response to your recent Freedom of
Information request.

 

Please could you supply any information you have regarding the trust's
policy on non-registered staff (eg. ambulance technicians) using
non-parenteral Prescription only medications such as salbutamol?

 

There is no current provision in law for emergency medical technicians to
make a decision to treat a person with non-parenteral prescription only
medicines. However, this practice is considered necessary for the urgent
and timely treatment of people using ambulance services. The trust
provides assurance on the delivery of safe and effective care through
considering the risks and having governance arrangements to mitigate and
manage this risk.

 

This includes the provision of scope of practice, clinical guidelines,
education and training and audit of use.

 

This practice is restricted to the use of salbutamol nebules only and only
in the absence of paramedics on scene.

 

Does the trust have a legal framework or policy that describes the legal
mechanism for this under the Human medicines regulations 2012?

As above, there is no current provision in law. A review has been
undertaken.

 

Has there ever been any feedback given or action taken by the MHRA or CQC
in relation to use of salbutamol or ipratropium bromide by ambulance
technicians?

There was a verbal discussion during  a CQC inspection in 2020, followed
up with evidence by the trust of the governance process in place.  The CQC
report (published in June 2020) stated:

Ambulance technicians treated patients with non-injected prescription-only
medicines. Although current legislation does not support this, the service
assessed and managed the risk, trained staff and assessed them as
competent. This ensured patients had timely access to safe and effective
treatment.

 

 

If the trust has a medicines policy or medicines governance policy, please
could you share this?

At this time the policy is under review.

 

 

 

Alice Finch

Communications Manager (interim)

Ext: 4797

 

 

 

show quoted sections